BSF ENTERPRISE PLC

11554014
Active London

Research and experimental development on biotechnology

14 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
B

BSF ENTERPRISE PLC

11554014

Research and experimental development on biotechnology

Founded 5 Sept 2018 Active London, England 14 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
Accounts Submitted 4 Mar 2026 Next due 31 Mar 2026 3 months overdue
Confirmation Submitted 13 Mar 2026 Next due 18 Sept 2020 70 months overdue
Net assets £3M £472K 2025 year on year
Total assets £3M £488K 2025 year on year
Total Liabilities £289K £16K 2025 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

2 Portman Street London W1H 6DU England

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for BSF ENTERPRISE PLC (11554014), an active life sciences and medical technology company based in London, England. Incorporated 5 Sept 2018. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Oct → 30 Sept 2025
Type group
Next accounts 30 Sept 2025
Due by 31 Mar 2026 3 months overdue

Balance Sheet & P&L (2019–2025)

Cash in Bank

£149.00k

Decreased by £489.00k (-77%)

Net Assets

£2.72M

Decreased by £472.00k (-15%)

Total Liabilities

£289.00k

Decreased by £16.00k (-5%)

Turnover

£477.00k

Increased by £260.00k (+120%)

Employees

14

Decreased by 1 (-7%)

Debt Ratio

10%

Increased by 1 (+11%)

Financial History

Revenue, profit, EBITDA and key financial figures

2025
30 Sept Year End
2024
30 Sept Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 2

Investors (1)

Investor NameInvestor SinceParticipating Rounds
Investor 1Dec 2024Secondary

Share Capital

Share Capital

Share allotments and capital structure

14 Allotments 151,534,435 Shares £250008.33m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
16 Apr 202638,500,000£385k£0.01
15 May 20254,725,000£142k£0.03
2 Jan 2025312,500£13k£0.04
4 Dec 202420,000,000£500k£0.025
26 Sept 2023100,000£17k£0.17

Officers

Officers

3 active
Status
Baker, GeoffDirectorAustralianUnited Kingdom695 Sept 2018Active
Che John ConnonDirectorBritishUnited Kingdom5417 May 2022Active
Min YangDirectorAustralianHong Kong595 Sept 2018Active

Shareholders

Shareholders (13)

Trade Hero Holdings Limited
29.5%
Advance Plan Investments Ltd
24.6%

Persons with Significant Control

Persons with Significant Control (0)

0 Active 2 Ceased

Min Yang

Ceased 26 Jul 2019

Ceased

Mr Geoff Baker

Ceased 26 Jul 2019

Ceased

Group Structure

Group Structure

BSF ENTERPRISE PLC Current Company
3D BIO-TISSUES LIMITED united kingdom
KERATO LIMITED united kingdom

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
21 Apr 2026CapitalAllotment of shares (GBP 1,668,744.37) on 16 Apr 2026
13 Mar 2026Confirmation StatementReplacement Filing Of Confirmation Statement With Made Up Date
11 Mar 2026ResolutionResolutions
4 Mar 2026Persons With Significant ControlCessation of Geoff Baker as a person with significant control on 26 Jul 2019
4 Mar 2026Persons With Significant ControlCessation of Min Yang as a person with significant control on 26 Jul 2019
21 Apr 2026 Capital

Allotment of shares (GBP 1,668,744.37) on 16 Apr 2026

13 Mar 2026 Confirmation Statement

Replacement Filing Of Confirmation Statement With Made Up Date

11 Mar 2026 Resolution

Resolutions

4 Mar 2026 Persons With Significant Control

Cessation of Geoff Baker as a person with significant control on 26 Jul 2019

4 Mar 2026 Persons With Significant Control

Cessation of Min Yang as a person with significant control on 26 Jul 2019

Recent Activity

Latest Activity

Allotment of shares (GBP 1,668,744.37) on 16 Apr 2026

1 months ago on 21 Apr 2026

Replacement Filing Of Confirmation Statement With Made Up Date

3 months ago on 13 Mar 2026

Resolutions

3 months ago on 11 Mar 2026

Cessation of Geoff Baker as a person with significant control on 26 Jul 2019

3 months ago on 4 Mar 2026

Cessation of Min Yang as a person with significant control on 26 Jul 2019

3 months ago on 4 Mar 2026